AZGP1 and cancer: The data indicates that before SNA enrichment, there is no significant difference in the levels of haptoglobin and zinc-alpha-2-glycoprotein between the normal and cancer serum samples, whereas cancer serum contained lower levels of the PON1 glycoprotein.